He discusses his session titled “The Microbiome and Fatty Liver Disease,” which he presented at Harvard’s Nonalcoholic Fatty Liver Disease (NAFLD): Mechanisms and Novel Therapeutics symposium.
Peter Traber, MD, discusses nonalcoholic steatohepatitis (NASH), which can progress over many years into cirrhosis and can potentially lead to the need for a liver transplant.
John E. Anderson, MD, discusses the details from his live presentation at the 2014 Summit on Metformin, and what physicians can prescribe following this treatment, with Co-Chair Edward Shahady, MD, FAAFP,...
